Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-28

Clinical Trial Update: Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of oral salmon calcitonin in knee osteoarthritis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Salmon Calcitonin (salmon calcitonin)

Snippet

Sponsor: Nordic Bioscience A/S | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-28